ME
Mark Elliott Boulding sold $174K of PTCT stock
Mark Elliott Boulding, Exec. VP And Clo of Ptc Therapeutics, Inc. (PTCT), sold 2,812 shares of PTCT stock worth $174K, per an SEC Form 4 filed Nov 18, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Nov 16, 2026, 2 days before it was made public.
PTCT has moved -7.5% since the trade date, from $60.97 to $56.42 (Nov 20, 2026 close).
- Traded
- Nov 16, 2026
- Disclosed
- Nov 18, 2026
- Filing delay
- 2 days
- Price since
- -7.5%
- Role
- Exec. VP And Clo
- Source
- SEC Form 4